Lupin LimitedNSE: LUPIN

Press Release Jan 06 2023

· Issued by Lupin Limited

Lupin Limited has informed the Exchange regarding a press release dated January 06, 2023, titled "Lupin Receives Approval from U.S. FDA for Fesoterodine Fumarate Extended-ReleaseTablets.".

View Attachment